References
- Anniko M, Mendel L. Cholesteatoma. A clinical and morphological analysis. Acta Otolaryngol 1981;91:275–83.
- Kim HJ, Tinling SP, Chole RA. Increased proliferation and migration of epithelium in advancing experimental cholesteatomas. Otol Neurotol 2002;23:840–4.
- Bujia J, Schilling V, Holly A. Hyperproliferation-associated keratin expression in human middle ear cholesteatoma. Acta Otolaryngol 1993;113:364–8.
- Olszewska E, Wagner M, Bernal-Sprekelsen M, Ebmeyer J, Dazert S, Hilmann H. Ethiopathogenesis of cholesteatoma. Eur Arch Otorhinolaryngol 2003;261:6–24.
- Shirakata Y, Kishimoto J, Tokumaru S, Yamasaki K, Hanakawa Y, Tohyama M, et al. Epiregulin, a member of the EGF family, is over-expressed in psoriatic epidermis. J Dermatol Sci 2007;45:69–72.
- Yarden Y, Sliwkowski MX. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2001;2:127–37.
- Citri A, Skaria KB, Yarden Y. The deaf and the dumb: the biology of ErbB-2 and ErbB-3. Exp Cell Res 2003;54–65.
- Shelly M, Pinkas-Kramarski R, Guarino BC, Waterman H, Wang LM, Lyass L, et al. Epiregulin is a potent pan-ErbB ligand that preferentially activates heterodimeric receptor complexes. J Biol Chem 1998;273:10496–505.
- Shirakata Y, Komurasaki T, Toyoda H, Hanakawa Y, Yamasaki K, Tokumaru S, et al. Epiregulin, a novel member of the epidermal growth factor family, is an autocrine growth factor in normal human keratinocytes. J Biol Chem 2000;275:5748–53.
- Cheshire IM, Blight A, Proops DW. An in vitro growth study on cholesteatoma and normal skin. Clin Otolaryngol Allied Sci 1995;20:453–60.
- Macias MP, Gerkin RD, Macias JD. Increased amphiregulin expression as a biomarker of cholesteatoma activity. Laryngoscope 2010;120:2258–63.
- Hoppe F. Proliferation behavior of cholesteatoma. HNO 1995;43:710–15.
- Yoshikawa M, Kojima H, Wada K, Tsukidate T, Okada N, Saito H, et al. Identification of specific gene expression profiles in fibroblasts derived from middle ear cholesteatoma. Arch Otolaryngol Head Neck Surg 2006;132:734–42.
- Bujia J, Holly A, Schilling V, Negri B, Pitzke P, Schulz P. Aberrant expression of epidermal growth factor receptor in aural cholesteatoma. Laryngoscope 1993;103:326–9.
- Bujia J, Kim C, Holly A, Sudhoff H, Ostos P, Kastenbauer E. Epidermal growth factor receptor (EGF-R) in human middle ear cholesteatoma: an analysis of protein production and gene expression. Am J Otol 1996;17:203–6.
- Ergün S, Zheng X, Carlsöö B. Expression of transforming growth factor alpha and epidermal growth factor receptor in middle ear cholesteatoma. Am J Otol 1996;17:393–6.
- Kojima H, Shiwa M, Kamide Y, Moriyama H. Expression and localization of mRNA for epidermal growth factor and epidermal growth factor receptor in human cholesteatoma. Acta Otolaryngol 1994;114:423–9.
- Hsu YC, Ho KY, Chai CY, Lee KW, Wang LF, Wu SC, et al. Expression of epidermal growth factor receptor in human middle ear cholesteatoma. Kaohsiung J Med Sci 2003;19:497–502.
- Shiwa M, Kojima H, Moriyama H. Expression of transforming growth factor-alpha (TGF-alpha) in cholesteatoma. J Laryngol Otol 1998;112:750–4.
- Sakamoto T, Kondo K, Yamasoba T, Suzuki M, Sugasawa M, Kaga K. Overexpression of ErbB-2 protein in human middle ear cholesteatomas. Laryngoscope 2004;114:1988–91.